Logo image of BZAI

BLAIZE HOLDINGS INC (BZAI) Stock Fundamental Analysis

NASDAQ:BZAI - Nasdaq - US0929151076 - Common Stock - Currency: USD

2.01  -0.01 (-0.5%)

After market: 2.04 +0.03 (+1.49%)

Fundamental Rating

1

BZAI gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 110 industry peers in the Semiconductors & Semiconductor Equipment industry. BZAI has a bad profitability rating. Also its financial health evaluation is rather negative. BZAI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BZAI had negative earnings in the past year.
In the past year BZAI has reported a negative cash flow from operations.
BZAI Yearly Net Income VS EBIT VS OCF VS FCFBZAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -20M -40M -60M -80M

1.2 Ratios

BZAI has a Return On Assets of -60.49%. This is amonst the worse of the industry: BZAI underperforms 89.09% of its industry peers.
Industry RankSector Rank
ROA -60.49%
ROE N/A
ROIC N/A
ROA(3y)-156.46%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BZAI Yearly ROA, ROE, ROICBZAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -200 -400

1.3 Margins

BZAI has a worse Gross Margin (12.88%) than 87.27% of its industry peers.
The Profit Margin and Operating Margin are not available for BZAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BZAI Yearly Profit, Operating, Gross MarginsBZAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -500 -1K -1.5K -2K

More info and screens

1

2. Health

2.1 Basic Checks

BZAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BZAI has more shares outstanding
BZAI has a worse debt/assets ratio than last year.
BZAI Yearly Shares OutstandingBZAI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 20M 40M 60M 80M 100M
BZAI Yearly Total Debt VS Total AssetsBZAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

BZAI has an Altman-Z score of -6.44. This is a bad value and indicates that BZAI is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -6.44, BZAI is doing worse than 81.82% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6.44
ROIC/WACCN/A
WACC10.66%
BZAI Yearly LT Debt VS Equity VS FCFBZAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 100M 200M

2.3 Liquidity

A Current Ratio of 2.14 indicates that BZAI has no problem at all paying its short term obligations.
BZAI has a Current ratio of 2.14. This is in the lower half of the industry: BZAI underperforms 70.00% of its industry peers.
A Quick Ratio of 1.93 indicates that BZAI should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.93, BZAI is doing worse than 60.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 1.93
BZAI Yearly Current Assets VS Current LiabilitesBZAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 10M 20M 30M 40M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for BZAI have decreased strongly by -718.00% in the last year.
EPS 1Y (TTM)-718%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, BZAI will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.09% on average per year.
BZAI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 224.31% yearly.
EPS Next YN/A
EPS Next 2Y4.92%
EPS Next 3Y12.09%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2Y195.2%
Revenue Next 3Y224.31%
Revenue Next 5YN/A

3.3 Evolution

BZAI Yearly Revenue VS EstimatesBZAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2025 2026 20M 40M 60M 80M 100M
BZAI Yearly EPS VS EstimatesBZAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0.2 -0.4 -0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BZAI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BZAI Price Earnings VS Forward Price EarningsBZAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BZAI Per share dataBZAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as BZAI's earnings are expected to grow with 12.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.92%
EPS Next 3Y12.09%

More info and screens

0

5. Dividend

5.1 Amount

BZAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLAIZE HOLDINGS INC

NASDAQ:BZAI (5/30/2025, 8:00:01 PM)

After market: 2.04 +0.03 (+1.49%)

2.01

-0.01 (-0.5%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)N/A N/A
Inst Owners24.41%
Inst Owner ChangeN/A
Ins Owners9.73%
Ins Owner Change16.88%
Market Cap204.38M
AnalystsN/A
Price TargetN/A
Short Float %1.97%
Short Ratio2.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 131.6
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.56
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS0.02
BVpS-1.05
TBVpS-1.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -60.49%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.88%
FCFM N/A
ROA(3y)-156.46%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.14
Quick Ratio 1.93
Altman-Z -6.44
F-Score3
WACC10.66%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-718%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2Y4.92%
EPS Next 3Y12.09%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2Y195.2%
Revenue Next 3Y224.31%
Revenue Next 5YN/A
EBIT growth 1Y-966.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y1.49%
EBIT Next 5YN/A
FCF growth 1Y-4483.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4339.91%
OCF growth 3YN/A
OCF growth 5YN/A